NSE ScannerComparison · NSE · data 2026-11-01
Bio Medica Laboratories Limited vs Medicamen Organics Ltd.
In plain words
Return on equity: Bio Medica Laboratories Limited 57.1% vs Medicamen Organics Ltd. -13.7%.
Debt to equity: Bio Medica Laboratories Limited 1.51 vs Medicamen Organics Ltd. 0.5.
Differences in the numbers, not a recommendation of either stock.
Side by side
| BMLL | MEDIORG | |
|---|---|---|
| Price | ₹149.95 | ₹26.5 |
| Market cap | — | ₹39 cr |
| P/E | — | — |
| P/B | — | — |
| ROE | 57.1% | -13.7% |
| ROCE | 48.5% | -15.0% |
| Debt / equity | 1.51 | 0.5 |
| Operating margin | — | -20.5% |
| Dividend yield | — | 0.00% |
| Sales growth, 3 years (yearly) | 38.5% | 0.7% |
| Profit growth, 3 years (yearly) | 228.1% | — |
| 1-year return | 34.8% | -24.6% |
| Revenue, last 12 months | — | ₹23 cr |
| Net profit, last 12 months | — | ₹-4 cr |
| Latest quarter | — | — |
| Quarter net profit | — | — |
| Quarter profit vs a year earlier | — | — |
| Promoter holding | — | — |
| Health check | Strong (8.5/10) | Weak (1.2/10) |
Common questions
Which earns a higher return on equity?
Bio Medica Laboratories Limited (57.1% against -13.7%).
Which carries more debt?
Bio Medica Laboratories Limited has the higher debt-to-equity ratio (1.51 against 0.5).